Publications by authors named "Benjamin Epstein"

Claim this Profile
A
A20 intrinsically influences human effector T-cell survival and function by regulating both NF-κB and JNK signaling.
Gina Dabbah-Krancher, Allison Ruchinskas, Melissa A Kallarakal, Katherine P Lee, Bradly M Bauman, Benjamin Epstein

Eur J Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of Ambient Magnetic Field Noise for Through-the-Earth (TTE) Communications and Historical Comparisons.
Chenming Zhou, David P Snyder, Benjamin Epstein, Zachary T Robinson, George Y Jin

IEEE Trans Electromagn Compat· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes.
Katherine P Lee, Benjamin Epstein, Camille M Lake, Andrew L Snow

Front Cell Death· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of pituitary cysts in growth hormone-treated children.
Matthew D Krasnow, Nicholas A Krasnow, Liam McGuirk, Tara P Patale, Sarah Manely, Benjamin Epstein

J Pediatr Endocrinol Metab· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty and spontaneous intracerebral hemorrhage: Does the modified frailty index predict mortality?
Michael G Kim, Chirag Gandhi, Ida Azizkhanian, Benjamin Epstein, Abhiniti Mittal

Clin Neurol Neurosurg· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
Benjamin E Epstein, David V Schaffer

Adv Exp Med Biol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.
Thomas Gaj, Benjamin E Epstein, David V Schaffer

Mol Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOVEL APPROACHES TO Topical Psoriasis Therapy.
Gregory Koyama, Jenny Liu, Alyse Scaffidi, Maryam Khazraee, Benjamin Epstein

Int J Pharm Compd· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confocal Adaptive Optics Imaging of Peripapillary Nerve Fiber Bundles: Implications for Glaucomatous Damage Seen on Circumpapillary OCT Scans.
Donald C Hood, Monica F Chen, Dongwon Lee, Benjamin Epstein, Paula Alhadeff

Transl Vis Sci Technol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline predictors of central aortic blood pressure: a PEAR substudy.
Rebecca F Rosenwasser, Niren K Shah, Steven M Smith, Xuerong Wen, Yan Gong, Benjamin Epstein

J Am Soc Hypertens· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT-2 inhibitors and their potential in the treatment of diabetes.
Rebecca F Rosenwasser, Senan Sultan, David Sutton, Rushab Choksi, Benjamin J Epstein

Diabetes Metab Syndr Obes· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of hypertension with fixed-dose triple-combination treatments.
Benjamin J Epstein, Niren K Shah, Nancy L Borja-Hart

Ther Adv Cardiovasc Dis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond.
Benjamin J Epstein, Paul T Leonard, Niren K Shah

Expert Rev Cardiovasc Ther· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin: a novel sodium-glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.
Niren K Shah, Wasim E Deeb, Rushab Choksi, Benjamin J Epstein

Pharmacotherapy· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: a comparison with atenolol (CENTRAL Study).
Niren K Shah, Steven M Smith, Wilmer W Nichols, Margaret C Lo, Umna Ashfaq, Benjamin J Epstein

J Clin Hypertens (Greenwich)· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less RAAS is more, or not.
Niren K Shah, Rushab Choksi, Benjamin J Epstein

Expert Rev Cardiovasc Ther· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional role of kallikrein 6 in regulating immune cell survival.
Isobel A Scarisbrick, Benjamin Epstein, Beth A Cloud, Hyesook Yoon, Jianmin Wu

PLoS One· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aliskiren and valsartan combination therapy for the management of hypertension.
Benjamin J Epstein

Vasc Health Risk Manag· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving blood pressure control rates by optimizing combination antihypertensive therapy.
Benjamin J Epstein

Expert Opin Pharmacother· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to obtain appropriate type 2 diabetes control in the first 180 days of treatment initiation.
Louis Kuritzky, Benjamin J Epstein, Frank Lavernia

Postgrad Med· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonpharmacological interventions for the treatment of rheumatoid arthritis: a focus on mind-body medicine.
Donna Leverone, Benjamin J Epstein

J Pharm Pract· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ticagrelor: a reversible P2Y12 receptor antagonist.
Shawn D Anderson, Niren K Shah, Juwon Yim, Benjamin J Epstein

Ann Pharmacother· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing peripheral edema in patients with arterial hypertension.
Benjamin J Epstein, Mary Ellen Roberts

Am J Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Mary Ellen Roberts, Benjamin J Epstein

J Cardiovasc Nurs· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent changes in the landscape of combination RAS blockade.
Benjamin J Epstein, Steven M Smith, Rushab Choksi

Expert Rev Cardiovasc Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis